Sahajanand Medical Technologies Ltd IPO - Check Issue Date, Price, Lot Size & Details with BlinkX.

Sahajanand Medical Technologies Ltd IPO

We are engaged in the development of Class III1 and Class C/D2 medical devices, with an emphasis on Vascular Intervention (VI) and Structural Heart (SH). Our portfolio of (i) VI products includes coronary intervention products such as coronary stents and coronary balloons, (ii) SH products includes Trans-Catheter Aortic Valves and Occluders, and (iii) other products including our own brand of renal stents, peripheral drug coated balloons and other trading products.

Sahajanand Medical Technologies Ltd IPO Details

Total Shares Offered

₹ 1,38,22,116

Offer to Public

1,38,22,116

Retail Max (Shares)

₹ 47,50,241

Pre Issue Promoters Holding

₹ 3,73,09,589

Exchange

COM

Issue size

₹ 475.48 Cr

IPO Open Date

Oct 15, 2026

Close Date

Oct 19, 2026

Lot Size

Min Investment

₹ 14,061

Issue Type

Book Building

Listing Date

Oct 23, 2026

Sahajanand Medical Technologies Ltd IPO Dates

Oct 15, 2026

Opening date

Oct 19, 2026

Closing date

Oct 21, 2026

Basis of Allotment

Oct 22, 2026

Initiation of Refunds

Oct 22, 2026

Credit of Shares

Oct 23, 2026

Listing date

Details

Sector	Type
Sector	Healthcare
Sub Sector	NA
Issue Type	Book Building

Subscription Status

*Values are in Lakhs

Investor Type	Subscription Times	Shares Offered*
QIB	0x	6786058
NII	0x	2035817
Retail	0x	4750241
Employee	0x	250000
Total	0x	13822116

Investor Type

QIB

NII

Retail

Employee

Total

Subscription Times

6786058

2035817

4750241

250000

13822116

Sahajanand Medical Technologies Ltd Financial Status

Income Statement

Particulars (In Rs. Crores)

Balance Sheet

Particulars (In Rs. Crores)

Particulars (in Rs. Crores)	FY23	FY22	FY21
Revenue from operations	1,024.88	901.60	795.55
EBITDA	29.70	37.34	69.19
PAT	-7.92	-34.46	20.73
Total Assets	395.11	325.35	337.79
Share Capital	9.76	9.75	9.75
Total Borrowings	225.62	129.14	99.54
Operating Activities (Net Cash)	8.58	-13.86	38.24
Investing Activities (Net Cash)	494.42	457.16	415.21
Financing Activities (Net Cash)	225.62	129.14	99.54
Net Cashflow	36.41	12.24	8.22

About Sahajanand Medical Technologies Ltd

Our Company was initially formed as a partnership firm named `Sahajanand Vascular Technoventions' pursuant to a partnership deed dated October 25, 1999. Subsequently, pursuant to a partnership deed dated September 30, 2001, the partnership firm was re-constituted, and the name of the partnership firm was changed to `Sahajanand Medical Technologies'. Subsequently, the partnership firm was converted into a joint stock company and was registered as a private limited company named `Sahajanand Medical Technologies Private Limited' pursuant to a certificate of incorporation dated October 18, 2001, issued by the Registrar of Companies, Gujarat, Dadra & Nagar Haveli, in accordance with provisions of the Companies Act, 1956. Subsequently, our Company was converted into a public limited company, pursuant to a special resolution of our Shareholders dated April 27, 2021, and the name of our Company was changed to `Sahajanand Medical Technologies Limited', and a fresh certificate of incorporation dated May 7, 2021 was issued to our Company by the Registrar of Companies, Gujarat at Ahmedabad (RoC).

The global vascular devices market can be segmented into Vascular Interventional Devices (comprising of cardiovascular and peripheral interventions) and Structural Heart Devices. The global vascular devices market has witnessed consistent growth over the past decade, driven by increasing prevalence of cardiovascular disease and peripheral vascular disease, technological advancements, and rising healthcare expenditure. In 2024, the market is valued at approximately USD 24.3 billion, with a 6.2% CAGR over the past five years.

Peer Comparison:

Sahajanand Medical Technologies Limited
Poly Medicure Limited
Laxmi Dental Limited

Sahajanand Medical Technologies Ltd Key Points

Strengths

Technologically advanced products in an industry with high barriers to entry;

Market leading position in interventional cardiology in India, leveraging on industry growth drivers;

Fast growth in international markets;

Robust and efficient manufacturing capabilities generating healthy margins;

Proven R&D capabilities;

Risk

We are subject to extensive regulatory requirements in applicable jurisdictions. Any adverse action by any authority against us would negatively impact our ability to offer our products to our clients and adversely impact our business and prospects.

Our manufacturing facilities are subject to certain risks, including quality control issues, disruptions in infrastructure facilities, and obsolete plant and machinery, which could increase our manufacturing costs or interrupt our operations and adversely impact our reputation, sales and strategies.

We are required to obtain, renew or maintain statutory and regulatory permits, licenses and approvals in relation to our manufacturing facilities, and any delay or inability in obtaining, renewing or maintaining such permits, licenses and approvals could result in an adverse effect on our business, financial condition, cash flows and results of operations. Further, our manufacturing facilities are subject to periodic inspections and audits by various regulatory authorities and clients.

Strategy

Leverage existing relationships by capturing cross-selling synergy in high growth vascular products and continue market leadership in India.

Continue to expand its international business

Entry into the U.S. and Japan markets

Continue to develop and optimize niche and high value products

Continue to explore strategic partnerships and acquisition opportunities to fast track its growth and become a global vascular device player

How To Apply for Sahajanand Medical Technologies Ltd IPO Online?

Step 1:

Step 2:

From the list of open IPOs, select the IPO you want to invest.

Step 3:

Go through the IPO details like lot size, price band, about the company, etc.

Step 4:

Click ‘Apply IPO’ to apply and enter the number of lots and bidding price along with your UPI ID.

Step 5:

Confirm your bid and accept the payment mandate sent to your UPI App for completing the IPO application.

FAQs on IPO (Initial Public Offering)

What is the issue size of the Sahajanand Medical Technologies Ltd IPO?

Sahajanand Medical Technologies Ltd's IPO offers shares for up to 0 It begins on Oct 15, 2026 and ends on Oct 19, 2026.

What is the price of the Sahajanand Medical Technologies Ltd IPO?

The price of Sahajanand Medical Technologies Ltd IPO ranges between ₹327 to ₹344 per share.

What are the open and close dates for the Sahajanand Medical Technologies Ltd IPO?

The Sahajanand Medical Technologies Ltd IPO opens on Oct 15, 2026 and closes on Oct 19, 2026.

When will the Sahajanand Medical Technologies Ltd IPO be allotted?

The allotment for the Sahajanand Medical Technologies Ltd IPO will be finalised on Oct 21, 2026. The shares will be listed on BSE and NSE on Oct 23, 2026.

What is the minimum lot size required for Sahajanand Medical Technologies Ltd IPO?

The minimum lot size for Sahajanand Medical Technologies Ltd IPO is 43 shares, priced between ₹327 to ₹344 per share.

What is the GMP of Sahajanand Medical Technologies Ltd IPO?

The GMP (Grey Market Premium) of Sahajanand Medical Technologies Ltd IPO fluctuates based on market demand and sentiment.

How do you check the allotment status of Sahajanand Medical Technologies Ltd IPO?

To check the allotment status of Sahajanand Medical Technologies Ltd IPO, visit the registrar's website, select the IPO, enter your PAN Card number, Application Number, or DP Client ID, and click 'search.'

Where is the Sahajanand Medical Technologies Ltd IPO getting listed?

The Sahajanand Medical Technologies Ltd IPO is getting listed on the BSE and NSE. Bidding opens on Oct 15, 2026, and closes on Oct 19, 2026. The allotment is finalised on Oct 21, 2026.

How do you apply for the Sahajanand Medical Technologies Ltd IPO?

To apply for the Sahajanand Medical Technologies Ltd IPO, download the BlinkX app, complete KYC, select the IPO, enter bid details, and submit. Verify UPI payment for shares allotment.